Thorac Cardiovasc Surg 1986; 34: 153-156
DOI: 10.1055/s-2007-1022195
© Georg Thieme Verlag Stuttgart · New York

Surgery of Pulmonary Metastases

H. J.C.M. van de Wal1 , A. Verhagen1 , A. Lecluyse1 , H. J. v. Lier2 , C. M. Jongerius3 , L. K. Lacquet1
  • 1Departments of Thoracic, Cardiac and Vascular Surgery, Sint Radboud University Hospital
  • 2Department of Statistic Consultation, Catholic University Nijmegen
  • 3Department of Pulmonology, Sint Radboud University Hospital, Nijmegen, and Medical Centre Bekkerswald, Groesbeek, The Netherlands
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
29. Mai 2008 (online)

Summary

From 1954 to 1985, 150 metastases were removed in 80 patients (55 males, 25 females) with an age range from 8 to 82 years. The role of pulmonary resection for metastastic lesions of the period 1954 to 1975 (group I) was compared to the period 1976 to 1985 (group II). In group I, 48 metastases were resected in 35 patients and in group II, 102 metastases in 45 patients. The surgical mortality in the total Population was 1 %. The average interval from diagnosis of the primary neoplasm to diagnosis of thoracic metastases was 4 years in both groups. Primary neoplasm localization did not differ in the 2 groups.

In both groups approximately 50% of the patients were without Symptoms. Wedge resection and lobectomy were the most frequent procedures followed by segmentectomy and pneumonectomy.

The median post thoracotomy survival was 21 months in group I and 36 months in group II. Although the tumorfree interval, presenting Symptoms and surgery did not differ in the 2 groups, the actuarial 5-year survival in group I was 31 %, and 53% for group II.

Neither sex, age nor the lung resection type significantly affected the therapeutic results. Good prognostic factors were a non-seminomatous testicular tumor as the primary tumor, a tumor-free interval longer than 60 months and a tumor-doubling time longer than 136 days. Poorer results were obtained in the presence of N2 metastases, and of a large tumor volume.

It seems that with the increased effectiveness of chemotherapy, especially in non-seminomatous testicular tumor, the role of surgery is changing.

Surgery is now also indicated to resect metastases unresponsive to chemotherapy and to obtain histology of stabilized lesions after chemotherapy.